1. 351 Sensitive pharmacodynamic assessment of PARP inhibitors for individualized treatment in clinic. (September 2015) Authors: Haan, R. De; Pluim, D.; Van Triest, B.; Verheij, M.; Schellens, J.H.M.; Vens, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0438: Clinical pharmacodynamics support biological effectivity of low dose olaparib as radiosensitizer. (November 2020) Authors: De Haan, R.; Pluim, D.; Verwijs, M.; Sonke, G.; Van den Heuvel, M.; Van Triest, B.; Vens, C.; Verheij, M. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗